A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Beard, Philippa M ^a   Griffiths, Samantha J ^b   Gonzalez, Orland ^c   Haga, Ismar R ^a   Jowers, Tali Pechenick ^a   Reynolds, Danielle K ^a   Wildenhain, Jan ^d   Tekotte, Hille ^d   Auer, Manfred ^d   Tyers, Mike ^d,e   Ghazal, Peter ^b   Zimmer, Ralf ^c   Haas, Jürgen ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ENHANCED GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HOST FACTOR; MESSENGER RNA; SEPTIN; SMALL INTERFERING RNA;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DNA REPAIR; GENE TARGETING; HIGH THROUGHPUT SCREENING; INSTRUMENT VALIDATION; LIFE CYCLE STAGE; NONHUMAN; PROCESS OPTIMIZATION; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA INTERFERENCE; RNA TRANSLATION; TRANSCRIPTION REGULATION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS REPLICATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; REPRODUCIBILITY; SIGNAL TRANSDUCTION; VACCINIA; VIROLOGY;

GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HIGH-THROUGHPUT SCREENING ASSAYS; HOST-PATHOGEN INTERACTIONS; HUMANS; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 84902532041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098431     Document Type: Article

References (74)

1. Gomez CE, Najera JL, Krupa M, Perdiguero B, Esteban M (2011) MVA and NYVAC as vaccines against emergent infectious diseases and cancer. Curr Gene Ther 11: 189-217.
2. Smith GL, Chan YS (1991) Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J Gen Virol 72 (Pt 3): 511-518.
3. Alcami A, Smith GL (1992) A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71: 153-167.
4. Upton C, Mossman K, McFadden G (1992) Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258: 1369-1372. (Pubitemid 23007791)
5. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, et al. (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A 97: 10162-10167.
6. Chang HW, Watson JC, Jacobs BL (1992) The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A 89: 4825-4829.
7. Chen RA, Ryzhakov G, Cooray S, Randow F, Smith GL (2008) Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog 4: e22.
8. Shisler JL, Jin XL (2004) The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol 78: 3553-3560. (Pubitemid 38568297)
9. Taylor JM, Barry M (2006) Near death experiences: poxvirus regulation of apoptotic death. Virology 344: 139-150. (Pubitemid 41814458)
10. Soares JA, Leite FG, Andrade LG, Torres AA, De Sousa LP, et al. (2009) Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J Virol 83: 6883-6899.
11. Hu N, Yu R, Shikuma C, Shiramizu B, Ostrwoski MA, et al. (2009) Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells. Vaccine 27: 2994-3006.
12. de Magalhaes JC, Andrade AA, Silva PN, Sousa LP, Ropert C, et al. (2001) A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J Biol Chem 276: 38353-38360.
13. Silva PN, Soares JA, Brasil BS, Nogueira SV, Andrade AA, et al. (2006) Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology. Biochem J 398: 83-95. (Pubitemid 44231303)
14. Maloney G, Schroder M, Bowie AG (2005) Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccha-ride-induced interleukin-10. J Biol Chem 280: 30838-30844. (Pubitemid 41291814)
15. Santos CR, Blanco S, Sevilla A, Lazo PA (2006) Vaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signaling. J Virol 80: 7667-7675. (Pubitemid 44092587)
16. Carter GC, Rodger G, Murphy BJ, Law M, Krauss O, et al. (2003) Vaccinia virus cores are transported on microtubules. J Gen Virol 84: 2443-2458. (Pubitemid 37063134)
17. Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, et al. (2009) Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods 6: 569-575.
18. Brown H, Prescott R (2006) Applied mixed models in medicine. Chichester, United Kingdom: John Wiley & Sons Ltd.
19. Pires de Miranda M, Reading PC, Tscharke DC, Murphy BJ, Smith GL (2003) The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol 84: 2459-2471. (Pubitemid 37063135)
20. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. (Pubitemid 41528093)
21. Ruepp A, Waegele B, Lechner M, Brauner B, Dunger-Kaltenbach I, et al. (2010) CORUM: the comprehensive resource of mammalian protein complexes-2009. Nucleic Acids Res 38: D497-501.
22. Luc PV, Tempst P (2004) PINdb: a database of nuclear protein complexes from human and yeast. Bioinformatics 20: 1413-1415.
23. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445. (Pubitemid 37033947)
24. Rubins KH, Hensley LE, Relman DA, Brown PO (2011) Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS One 6: e15615.
25. Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B (2010) Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc Natl Acad Sci U S A 107: 11513-11518.
26. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
27. Coyne CB, Bozym R, Morosky SA, Hanna SL, Mukherjee A, et al. (2011) Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 9: 70-82.
28. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, et al. (2009) Discovery of insect and human dengue virus host factors. Nature 458: 1047-1050.
29. Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, et al. (2011) RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci U S A 108: 19036-19041.
30. Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, et al. (2009) A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci U S A 106: 16410-16415.
31. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, et al. (2010) Genomewide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463: 818-822.
32. Mercer J, Snijder B, Sacher R, Burkard C, Bleck CK, et al. (2012) RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep 2: 1036-1047.
33. Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, et al. (2013) A systematic analysis of host factors reveals a Med23-interferon-lambda regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog 9: e1003514.
34. Humphries AC, Dodding MP, Barry DJ, Collinson LM, Durkin CH, et al. (2012) Clathrin potentiates vaccinia-induced actin polymerization to facilitate viral spread. Cell Host Microbe 12: 346-359.
35. Husain M, Moss B (2003) Evidence against an essential role of COPII-mediated cargo transport to the endoplasmic reticulum-Golgi intermediate compartment in the formation of the primary membrane of vaccinia virus. J Virol 77: 11754-11766. (Pubitemid 37271673)
36. Moser TS, Jones RG, Thompson CB, Coyne CB, Cherry S (2010) A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics. PLoS Pathog 6: e1000954.
37. Haga IR, Pechenick Jowers T, Griffiths SJ, Haas J, Beard PM (2014) TRAF2 Facilitates Vaccinia Virus Replication by Promoting Rapid Virus Entry. J Virol 88: 3664-3677.
38. Sivan G, Martin SE, Myers TG, Buehler E, Szymczyk KH, et al. (2013) Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. Proc Natl Acad Sci U S A 110: 3519-3524.
39. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437.
40. Hirsch AJ (2010) The use of RNAi-based screens to identify host proteins involved in viral replication. Future Microbiol 5: 303-311.
41. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926. (Pubitemid 351263756)
42. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
43. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4: 495-504.
44. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, et al. (2008) RNA interference screen for human genes associated with West Nile virus infection. Nature 455: 242-245.
45. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, et al. (2009) A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5: 298-307.
46. Clemente R, Sisman E, Aza-Blanc P, de la Torre JC (2010) Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen. J Virol 84: 3562-3575.
47. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, et al. (2010) Human host factors required for influenza virus replication. Nature 463: 813-817.
48. Iwamoto M, Asakawa H, Hiraoka Y, Haraguchi T (2010) Nucleoporin Nup98: a gatekeeper in the eukaryotic kingdoms. Genes Cells 15: 661-669.
49. Kiss A, Li L, Gettemeier T, Venkatesh LK (2003) Functional analysis of the interaction of the human immunodeficiency virus type 1 Rev nuclear export signal with its cofactors. Virology 314: 591-600. (Pubitemid 37206363)
50. Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, et al. (2007) Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci U S A 104: 1853-1858. (Pubitemid 46239868)
51. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, et al. (2008) Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454: 890-893.
52. Townsley AC, Weisberg AS, Wagenaar TR, Moss B (2006) Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J Virol 80: 8899-8908. (Pubitemid 44359964)
53. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523.
54. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7: e1001258.
55. Lu J, Pan Q, Rong L, He W, Liu SL, et al. (2011) The IFITM proteins inhibit HIV-1 infection. J Virol 85: 2126-2137.
56. Smith S, Weston S, Kellam P, Marsh M (2014) IFITM proteins-cellular inhibitors of viral entry. Curr Opin Virol 4C: 71-77.
57. De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Ferec C, et al. (2011) RUNX1 translocations and fusion genes in malignant hemopathies. Future Oncol 7: 77-91.
58. Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, et al. (2012) Genome-wide association study of antibody response to smallpox vaccine. Vaccine 30: 4182-4189.
59. Boone RF, Moss B (1978) Sequence complexity and relative abundance of vaccinia virus mRNA's synthesized in vivo and in vitro. J Virol 26: 554-569. (Pubitemid 8344844)
60. Brum LM, Lopez MC, Varela JC, Baker HV, Moyer RW (2003) Microarray analysis of A549 cells infected with rabbitpox virus (RPV): a comparison of wild-type RPV and RPV deleted for the host range gene, SPI-1. Virology 315: 322-334. (Pubitemid 37324622)
61. Shors T, Keck JG, Moss B (1999) Down regulation of gene expression by the vaccinia virus D10 protein. J Virol 73: 791-796. (Pubitemid 28565429)
62. Parrish S, Moss B (2006) Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression. J Virol 80: 553-561. (Pubitemid 43062867)
63. Broyles SS (2003) Vaccinia virus transcription. J Gen Virol 84: 2293-2303.
64. Nagata K, Asano T, Nozawa Y, Inagaki M (2004) Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11. J Biol Chem 279: 55895-55904. (Pubitemid 40066597)
65. Cao L, Yu W, Wu Y, Yu L (2009) The evolution, complex structures and function of septin proteins. Cell Mol Life Sci 66: 3309-3323.
66. Mostowy S, Bonazzi M, Hamon MA, Tham TN, Mallet A, et al. (2010) Entrapment of intracytosolic bacteria by septin cage-like structures. Cell Host Microbe 8: 433-444.
67. Cudmore S, Cossart P, Griffiths G, Way M (1995) Actin-based motility of vaccinia virus. Nature 378: 636-638.
68. Doceul V, Hollinshead M, van der Linden L, Smith GL (2010) Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327: 873-876.
69. Li GM (2008) Mechanisms and functions of DNA mismatch repair. Cell Res 18: 85-98.
70. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14: 927-939. (Pubitemid 30253002)
71. Lilley CE, Schwartz RA, Weitzman MD (2007) Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol 15: 119-126. (Pubitemid 46356979)
72. Wenzel M, Wunderlich M, Besch R, Poeck H, Willms S, et al. (2012) Cytosolic DNA triggers mitochondrial apoptosis via DNA damage signaling proteins independently of AIM2 and RNA polymerase III. J Immunol 188: 394-403.
73. Kahn BB, Alquier T, Carling D, Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25. (Pubitemid 43960587)
74. Lee JH, Koh H, Kim M, Kim Y, Lee SY, et al. (2007) Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447: 1017-1020. (Pubitemid 46975745)